Develops drugs for multiple sclerosis and migraine.
Jun 2026Revenue $17.3B/yrExpenses $15.7B/yr
No trend
Figures by year
Is Teva Pharmaceutical Industries profitable?
Yes. In the 12 months to Jun 2026, revenue was $17.3B and expenses $15.7B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $17.3B | $15.1B | $2.16B |
| Dec 2024 | $16.5B | $16.8B | −$303M |
| Dec 2023 | $15.8B | $15.4B | $433M |
| Dec 2022 | $14.9B | $17.1B | −$2.20B |
| Dec 2021 | $15.9B | $14.2B | $1.72B |
| Dec 2020 | $16.7B | $20.2B | −$3.57B |
| Dec 2019 | $16.9B | $17.3B | −$443M |
| Dec 2018 | $18.3B | $19.9B | −$1.64B |
| Dec 2017 | $21.9B | $39.3B | −$17.5B |
| Dec 2016 | $21.9B | $19.7B | $2.15B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.